Indress-Hauser, specialized in process instrumentation, has acquired a stake in Finesse Solutions, an American company that develops, produces and distributes sensors, hardware and software for bioengineering.
Through this cooperation, Endress-Hauser intends to strengthen its position in the field of biotechnology. "Biotech procedures will play an increasingly important role in the future, not only in the life sciences industry but also in all other industries, such as the chemical industry, to produce products in a more economical and environmentally friendly way," said Klaus Endress, President and CEO of the Endress-HauserGroup. "Our partnership with Finesse gives us the opportunity to gain experience in this field without neglecting our core business."
The previous majority shareholder, Skymoon Ventures, will hold a stake equal to that of'Endress-Hauser. The company's staff, approximately 50 people, will retain their stake in the company. Endress-Hauser will elect two representatives to the Board of Directors, which Barbara A Paldus will continue to chair.
Find out more: www.fr.endress.com/